Abstract
Good progress has been made to modernize traditional Chinese medicines by obtaining active components from natural herbs. In this review, some recent works on procuring active components and modernizing traditional Chinese medicines will be covered. In addition, some recent works on drug design using modern drug design tools have been described. With some well defined targets, the traditional Chinese medicine databases have been screened so as to identify those compounds for which the potential as a drug candidate was not known before. Among these studies, two have been selected as examples to be discussed in details. First, new anti-HIV candidates have been detected, namely leucovorin and agaritine derivatives. Subsequently, GTS-21 is proved to be a good candidate for Alzheimers disease. All these findings may provide useful information for finding effective drug candidates with lower cost.
Keywords: Drug candidates, traditional chinese medicine, natural herbs, modern drug design tools
Current Topics in Medicinal Chemistry
Title: Drug Candidates from Traditional Chinese Medicines
Volume: 8 Issue: 18
Author(s): Jing-Fang Wang, Dong-Qing Wei and Kuo-Chen Chou
Affiliation:
Keywords: Drug candidates, traditional chinese medicine, natural herbs, modern drug design tools
Abstract: Good progress has been made to modernize traditional Chinese medicines by obtaining active components from natural herbs. In this review, some recent works on procuring active components and modernizing traditional Chinese medicines will be covered. In addition, some recent works on drug design using modern drug design tools have been described. With some well defined targets, the traditional Chinese medicine databases have been screened so as to identify those compounds for which the potential as a drug candidate was not known before. Among these studies, two have been selected as examples to be discussed in details. First, new anti-HIV candidates have been detected, namely leucovorin and agaritine derivatives. Subsequently, GTS-21 is proved to be a good candidate for Alzheimers disease. All these findings may provide useful information for finding effective drug candidates with lower cost.
Export Options
About this article
Cite this article as:
Wang Jing-Fang, Wei Dong-Qing and Chou Kuo-Chen, Drug Candidates from Traditional Chinese Medicines, Current Topics in Medicinal Chemistry 2008; 8 (18) . https://dx.doi.org/10.2174/156802608786786633
DOI https://dx.doi.org/10.2174/156802608786786633 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Biological Evaluation and Pharmacokinetic Studies of Mefenamic Acid - N-Hydroxymethylsuccinimide Ester Prodrug as Safer NSAID
Medicinal Chemistry Neuroimaging of Serotonin System in Anxiety Disorders
Current Pharmaceutical Design Adenosine and the Auditory System
Current Neuropharmacology A Mesenchymal Stem Cell Line Transplantation Improves Neurological Function and Angiogenesis in Intraventricular Amyloid β-Infused Rats
Current Alzheimer Research Dry Age-Related Macular Degeneration: Recent Progress of Therapeutic approaches
Current Molecular Pharmacology Small Molecule Approaches for Promoting Neurogenesis
Current Alzheimer Research Identification of Crucial Genes and Diagnostic Value Analysis in Major Depressive Disorder Using Bioinformatics Analysis
Combinatorial Chemistry & High Throughput Screening Experimental Methods for Studying the Interactions between G-Quadruplex Structures and Ligands
Current Pharmaceutical Design Amyloid β-Peptide: The Inside Story
Current Alzheimer Research Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Olanzapine-Induced Reversible Pellagroid Skin Lesion
Current Drug Safety Obstructive Sleep Apnea Syndrome: From Phenotype to Genetic Basis
Current Genomics Epigenetic Basis of Individual Variability to Major Psychosis
Current Pharmacogenomics and Personalized Medicine Gq protein-Coupled Receptors as Targets for Anesthetics
Current Pharmaceutical Design Omega-3 Fatty Acids and Hippocampal Neurogenesis in Depression
CNS & Neurological Disorders - Drug Targets Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
CNS & Neurological Disorders - Drug Targets Factors Affecting the Metabolite Productions in Endophytes: Biotechnological Approaches for Production of Metabolites
Current Medicinal Chemistry The Role of Natural Killer T Cells in Atherosclerosis
Current Immunology Reviews (Discontinued) Conference Report (42nd Annual Meeting of the Italian Society of Neurology, 22-25 October 2011, Turin, Italy)
CNS & Neurological Disorders - Drug Targets